1. Market Research
  2. > Pharmaceutical Market Trends
  3. > South Africa Pharmaceuticals and Healthcare Report Q1 2016

South Africa Pharmaceuticals and Healthcare Report Q1 2016

  • December 2015
  • -
  • Business Monitor International
  • -
  • 114 pages

Includes 3 FREE quarterly updates

BMI View: A compulsory licence for Aluvia in South Africa remains unlikely given that country'sreluctance to resort to such measures The request puts pressure on AbbVie to address supply issues, butmore importantly reminds South Africa's government that expectations over the stalled efforts to amend thecountry's patent laws remain high The government has made assurances that movement will be seen inQ116; failure to do so will risk a political storm

Headline Expenditure Projections

- Pharmaceuticals: ZAR3979bn (USD367bn) in 2014 to ZAR4341bn (USD344bn) in 2015; +91% inlocal currency terms and -62% in US dollar terms Forecast in US dollar terms revised slightlydownwards from last quarter

-Healthcare: ZAR3252bn (USD2998bn) in 2014 to ZAR35106bn (USD2782bn) in 2015; +80% inlocal currency terms and -72% in US dollar terms Forecast in US dollar terms revised slightlydownwards from last quarter

Table Of Contents

South Africa Pharmaceuticals and Healthcare Report Q1 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (South Africa 2013-2019) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (South Africa 2011-2019) 12
Healthcare Market Forecast 13
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (South Africa 2011-2019) 14
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (South Africa 2011-2019) 15
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (South Africa 2011-2019) 15
Prescription Drug Market Forecast 16
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (South Africa 2011-2019) 17
Patented Drug Market Forecast 18
Table: Patented Drug Market Indicators, Historical Data And Forecasts (South Africa 2011-2019) 20
Generic Drug Market Forecast 21
Table: Generic Drug Market Indicators, Historical Data And Forecasts (South Africa 2011-2019) 22
OTC Medicine Market Forecast 23
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (South Africa 2011-2019) 25
Pharmaceutical Trade Forecast 26
Table: Pharmaceutical Trade Data And Forecasts (South Africa 2013-2019) 27
Table: Pharmaceutical Trade Data And Forecasts local currency (South Africa 2013-2019) 27
Industry Risk/Reward Index 28
Middle East and Africa Risk/Reward Index - Q1 2016 28
South Africa Risk/Reward Index 36
Rewards 36
Risks 37
Regulatory Review 38
Table: Drug Classification System 38
Regulatory Developments 41
Intellectual Property Issues 43
Pricing Regime 46
Table: Tiered Pharmaceutical Pricing System Is Better Than A Flat Fixed Mark-Up 46
Reimbursement Regime 47
Market Overview 49
Healthcare Sector 51
Public Healthcare Sector 51
Private Healthcare Sector 53
Healthcare Infrastructure 57
Table: Healthcare Resources (South Africa 2009-2014) 58
Table: Healthcare Personnel (South Africa 2009-2014) 58
Table: Healthcare Activity (South Africa 2009-2014) 59
Research and Development Sector 59
Clinical Trials 60
Vaccines 62
Traditional African Medicine 62
Telemedicine 63
Epidemiology 64
Competitive Landscape 68
Research-Based Pharmaceutical Industry 68
Table: Multinational Market Activity 69
Generic Drugmakers 70
Pharmaceutical Retail Sector 72
Private Healthcare Market 74
Company Profile 76
Aspen Pharmacare 76
Adcock Ingram 80
Cipla Medpro 85
GlaxoSmithKline 88
Novartis 93
Pfizer 95
Roche 98
Sanofi 100
Demographic Forecast 103
Demographic Outlook 103
Table: Population Headline Indicators (South Africa 1990-2025) 104
Table: Key Population Ratios (South Africa 1990-2025) 104
Table: Urban/Rural Population and Life Expectancy (South Africa 1990-2025) 105
Table: Population By Age Group (South Africa 1990-2025) 105
Table: Population By Age Group % (South Africa 1990-2025) 106
Glossary 108
Methodology 110
Pharmaceutical Expenditure Forecast Model 110
Healthcare Expenditure Forecast Model 110
Notes On Methodology 111
Risk/Reward Index Methodology 112
Index Overview 113
Table: Pharmaceutical Risk/Reward Index Indicators 113
Indicator Weightings 114

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025 Summary Atrial fibrillation (AF) is the most common cardiac arrhythmia and is a heart condition that causes an irregula ...

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025 Summary Venous thromboembolism (VTE) is a disease that includes a myriad of life-threatening disorders ranging from ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.